Motley Fool Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Motley Fool Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14,062	Closed	-$651K	–	169
2019 Q4	$651K	Sell	14,062 -480	-3%	-$20.8K	0.07%	125
2019 Q3	$592K	Sell	14,542 -15,488	-52%	-$669K	0.07%	129
2019 Q2	$1.45M	Buy	30,030 +488	+2%	+$25.7K	0.16%	89
2019 Q1	$1.85M	Buy	29,542 +4,880	+20%	+$335K	0.21%	83
2018 Q4	$1.47M	Buy	+24,662	New	+$1.48M	0.21%	75

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Motley Fool Asset Management's BEAT Position: Q1 2020 in Review

Motley Fool Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 14,062 shares — an estimated $651K sold.

Motley Fool Asset Management first reported a position in BEAT in Q4 2018 and held it in 5 quarters. The position peaked at $1.85M in Q1 2019. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

Motley Fool Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
Motley Fool Asset Management sold 14,062 BioTelemetry, Inc. shares in Q1 2020, an estimated $651K.
Motley Fool Asset Management first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 5 quarters.
Motley Fool Asset Management's BioTelemetry, Inc. position peaked at $1.85M in Q1 2019.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Motley Fool Asset Management's 13F filing for Q1 2020, filed 13 May 2020.